July 16 marked the grand opening of WHX Labs Kuala Lumpur 2025 at MITEC Malaysia, the flagship healthcare expo across Southeast Asia. Centered on innovation and synergy, BIOELAB kicked off a brand-new journey with a lineup of premium core products unveiled at the show.
As a unified platform under World Health Expo brand, WHX Labs Kuala Lumpur 2025 gathers thousands of global medical practitioners, industrial leaders and innovators. It serves as a pivotal hub for industry networking, cutting-edge medical equipment & diagnostic technology exchange, digital healthcare and lab innovation, as well as tapping into booming growth opportunities within ASEAN’s thriving medical market.
Boasting a large population base, robust economic expansion and surging healthcare demands, Southeast Asia has been fueling continuous transformation and expansion of the IVD industry. BIOELAB’s participation in the Kuala Lumpur exhibition is a crucial milestone to break into this promising blue-ocean market.
At WHX Labs Kuala Lumpur 2025, BIOELAB showcased flagship products covering chemiluminescence, biochemistry, coagulation and hematology analyzers. Backed by robust proprietary technology and premium workmanship, our full-range IVD solutions paired with intelligent system stood out prominently.
The booth enjoyed consistent high traffic on the opening day, attracting regular and prospective clients to experience our cutting-edge technologies on-site. Our team delivered detailed product introduction and live demonstration, enabling visitors to intuitively experience the efficiency and user-friendliness of BIOELAB’s IVD devices.
Starting with a semi-automatic biochemistry analyzer 15 years ago, BIOELAB has evolved into a professional IVD manufacturer with a modern R&D and production base covering around 40 mu of land. Our business footprint spans over 80 countries, with more than 60,000 equipment installations worldwide.
Throughout the exhibition, numerous clients were impressed by the outstanding performance and innovative technology of BIOELAB’s flagship products, with multiple enterprises reaching preliminary cooperation intentions.
WHX Labs Kuala Lumpur is still ongoing, alongside BIOELAB’s persistent exploration in the IVD sector. Keeping moving forward toward long-term development, BIOELAB looks forward to collaborating with all industry partners to unlock unlimited potentials of in-vitro diagnostics and scale new heights together in the future.
